Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

No phase data

Trial Status

Completed1
Other4

Role Distribution

Principal Investigator1
Other Roles4
PI Rate20%

Activity Timeline

Clinical Trials (5)

The Short-term Efficacy of Novel NTDP-RFA in the Treatment of Small HCC With Cirrhosis.
Hepatocellular Carcinoma Stage IRadiofrequency Ablation
StudydirectorStart date: 2017-01-01
NCT03890328Not ApplicableCompleted
RF-assisted Splenic Preservation VS Conventional Treatment of Blunt Splenic Injury.
Radiofrequency Can be Used to Treat Splenic Trauma Because of Its Excellent Coagulation Hemostasis
PrincipalinvestigatorStart date: 2009-03-01
NCT02299843Not ApplicableUnknown
RALPPS Venus ALPPS for Hepatocellular Carcinoma
Hepatocellular Carcinoma
Studydirector

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Publications (0)

No publications found for this investigator.

Clinical Trials (5)

Showing 5 of 5 trials

NCT04513119StudyDirector

The Short-term Efficacy of Novel NTDP-RFA in the Treatment of Small HCC With Cirrhosis.

Hepatocellular Carcinoma Stage IRadiofrequency Ablation
Unknown
NCT03890328Not ApplicablePrincipalInvestigator

RF-assisted Splenic Preservation VS Conventional Treatment of Blunt Splenic Injury.

Radiofrequency Can be Used to Treat Splenic Trauma Because of Its Excellent Coagulation Hemostasis
Completed
NCT01713244Not ApplicableStudyDirector

Radiofrequency Ablation Assisted Hepatectomy Versus Hepatectomy Alone for Advanced Hepatocellular Carcinoma

Hepatocellular Carcinoma
Unknown
NCT02299843Not ApplicableStudyDirector

RALPPS Venus ALPPS for Hepatocellular Carcinoma

Hepatocellular Carcinoma
Unknown
NCT03790059Not ApplicableStudyDirector

Radiofrequency Ablation Combined With Recombinant Human Adenovirus Type 5 in the Treatment of Hepatocellular Carcinoma.

Hepatocellular Carcinoma
Unknown

All 5 trials loaded